Clinical trial
Impact of Metabolic Health on Sperm Epigenetic Marks in Humans
NCT03860558 is registered in ClinicalTrials.gov with Joslin Diabetes Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Metabolic Health on Sperm Epigenetic Marks in Humans
- Lead sponsor
- Joslin Diabetes Center
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- May 1, 2018
- Completion date
- July 1, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
overweight, type 1 diabetes mellitus, type 2 diabetes mellitus